NCM·Healthcare·$1.0B·#79 / 520 in Healthcare
BLFS BioLife Solutions, Inc.
67SOLID
CATEGORY BREAKDOWN
GROWTH46
QUALITY70
STABILITY99
VALUATION43
GOVERNANCE41
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+28.9%
46
> 50% strong
Gross Margin
Revenue retained after direct costs
64.6%
92
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
4.8%
96
< 25% strong
Price / Sales
Market cap relative to trailing revenue
10.7x
43
< 3x strong
Rule of 40
Growth rate plus operating margin
12
37
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
2.4%
19
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+2.8%
83
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE BLFS WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when BLFS's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.